Science Explorer Back to mapMap
Discussion
Researcher · University of Lisbon · Portugal

Julie C. Ribot

Julie C. Ribot publishes mostly in Immunology, Oncology and Neurology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses.

ORCID 0000-0002-7852-343X OpenAlex
World rank
#733,098
of 7,710,434 ranked researchers
Rank in Portugal
#2,659
of 41,760
Works
56
Citations
3.6k
Citations per work
64.3
h-index
23
i10-index 28Top 25% in Immunology
Julie C. Ribot

What does Julie C. Ribot research?

Julie C. Ribot's work is mostly in Immunology and Microbiology (69%), Medicine (14%), Neuroscience (5%).

Life Sciences: 43 works · 76.2% of their workImmunology and Microbiology: 39 works · 68.9% of their workImmunology: 39 works · 68.9% of their workNeuroscience: 3 works · 5.3% of their workNeurology: 3 works · 5.3% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 2.0% of their workMolecular Biology: 1 works · 2.0% of their workHealth Sciences: 8 works · 13.9% of their workMedicine: 8 works · 13.9% of their workOncology: 5 works · 9.3% of their workPulmonary and Respiratory Medicine: 1 works · 2.6% of their workPublic Health, Environmental and Occupational Health: 1 works · 2.0% of their workEverything else: 6 works · 9.9% of their workTHEIR WORKJulie C. Ribot56works
Life Sciences76%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology3968.9%
    2. Neuroscience35.3%
    3. Biochemistry, Genetics and Molecular Biology12.0%
    1. Medicine813.9%
  3. Everything else69.9%
  1. 1Immunology69% of their works
  2. 2Oncology9% of their works
  3. 3Neurology5% of their works
  4. 4Pulmonary and Respiratory Medicine3% of their works
  5. 5Public Health, Environmental and Occupational Health2% of their works
  6. 6Molecular Biology2% of their works

Research topics

Which keywords describe Julie C. Ribot's research?

The keywords of their largest research topics: Foxp3, Natural Killer Cells, NK Cell Recognition, TGF-ß, Innate Immunity, Dendritic Cells, Cancer Immunotherapy and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Foxp3341 topic
  2. NK Cell Recognition341 topic
  3. Natural Killer Cells341 topic
  4. TGF-ß341 topic
  5. Innate Immunity262 topics
  6. Dendritic Cells232 topics
  7. Cancer Immunotherapy201 topic
  8. Immunity201 topic
  9. Cytokines92 topics
  10. Inflammation82 topics
  11. Regulatory T Cells72 topics
  12. Microglia61 topic
  13. Neuroinflammation61 topic
  14. Immune Checkpoint Blockade51 topic
  15. PD-1 and PD-L151 topic
  16. Pattern Recognition Receptors51 topic
  17. Toll-like Receptors51 topic
  18. IL-3341 topic
  19. Innate Lymphoid Cells41 topic
  20. Atherosclerosis31 topic
  21. Immune Response31 topic

Where does Julie C. Ribot work?

Julie C. Ribot's main affiliation in the publication record is University of Lisbon, Portugal.

How many publications and citations does Julie C. Ribot have?

OpenAlex counts 56 works and 3,601 citations for Julie C. Ribot, an h-index of 23, ranking #733,098 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Julie C. Ribot. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.